Physician profile
Michael Look
NPI 1861677601
$4,081.71
in general payments reported to CMS, 2019-2025
42 companies · $1,182 in 2025
The $1,182 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $73.55 · 2021: $128 · 2022: $550 · 2023: $823 · 2024: $1,002 · 2025: $1,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,007.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $474.33 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $447.50 | 2019-2025 | |
| Abbott Laboratories | $335.91 | 2020-2025 | Freestyle Libre 3, Proclaim |
| Lilly USA, LLC | $276.06 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $196.99 | 2022-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Amgen INC. | $191.84 | 2019-2025 | Otezla, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $182.70 | 2019-2025 | Airsupra, Farxiga, Flumist Quadrivalent |
| Edwards Lifesciences Corporation | $172.12 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Daiichi Sankyo INC. | $153.32 | 2019-2025 | Injectafer |
| Boston Scientific Corporation | $132.27 | 2024 | Watchman Flx |
| Exact Sciences Corporation | $127.19 | 2023-2025 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $126.50 | 2022 | |
| Sanofi-Aventis U.S. LLC | $110.30 | 2022-2025 | |
| Axsome Therapeutics, INC. | $83.94 | 2025 | Auvelity |
| Phathom Pharmaceuticals, INC. | $74.77 | 2024-2025 | Voquezna |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $74.54 | 2019-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $72.21 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $64.35 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Medtronic, INC. | $62.13 | 2022-2025 | Cd Horizon Spinal System, Venaseal, Inceptiv |
| Janssen Pharmaceuticals, INC | $62.13 | 2020-2025 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $60.89 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.43 | 2019-2024 | |
| Dynavax Technologies Corporation | $53.04 | 2023 | Heplisav-B |
| Xeris Pharmaceuticals, INC. | $49.25 | 2020-2025 | Gvoke Hypopen |
| Radius Health, INC. | $48.70 | 2025 | |
| Idorsia Pharmaceuticals US INC | $47.20 | 2022-2023 | Quviviq |
| Grt US Holding, INC. | $33.03 | 2022 | |
| Eisai INC. | $32.47 | 2025 | |
| Esperion Therapeutics, INC. | $28.85 | 2024 | Nexletol |
| Aimmune Therapeutics, INC. | $26.70 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.01 | 2019 | |
| Organogenesis INC. | $23.14 | 2025 | Apligraf |
| Renalytix Ai, INC. | $23.03 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Lundbeck LLC | $21.76 | 2022 | |
| Sanofi Pasteur INC. | $21.30 | 2023 | |
| Alk-Abello, INC | $20.91 | 2025 | Ragwitek, Grastek |
| Amarin Pharma, INC. | $17.49 | 2020 | |
| Photonicare INC | $16.76 | 2024 | Otosight Middle Ear Scope |
| Global Blood Therapeutics, INC. | $15.34 | 2022 | |
| Noven Therapeutics, LLC | $14.09 | 2024 | Xelstrym |
| Horizon Therapeutics Plc | $13.75 | 2019 | |
| Biogen, INC. | $13.47 | 2025 | Leqembi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Look listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.